Overview

Heterologous Effects of BCG in Healthy UK Adults

Status:
Completed

Trial end date:
2016-11-01

Target enrollment:

Participant gender:

Summary

TB038 is a clinical study to assess the non-specific effects of BCG vaccination and gain a better understanding of how the body's immune system reacts to BCG and in turn potentially prevents infection from other bacteria.

Phase:

N/A

Details

Lead Sponsor:

University of Oxford

Treatments:

Vaccines